TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994
TCL Archive In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas February 3, 1984
TCL Archive Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says February 13, 1998